These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32800880)

  • 1. Producing physicochemical property consensus alphavirus protein antigens for broad spectrum vaccine design.
    Baker WS; Negi S; Braun W; Schein CH
    Antiviral Res; 2020 Oct; 182():104905. PubMed ID: 32800880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCP consensus protein/peptide alphavirus antigens stimulate broad spectrum neutralizing antibodies.
    Schein CH; Rafael G; Baker WS; Anaya ES; Schmidt JG; Weaver SC; Negi S; Braun W
    Peptides; 2022 Nov; 157():170844. PubMed ID: 35878658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing multivalent immunogens for alphavirus vaccine optimization.
    Read CM; Plante K; Rafael G; Rossi SL; Braun W; Weaver SC; Schein CH
    Virology; 2021 Sep; 561():117-124. PubMed ID: 33823988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic interference from sequential administration of live attenuated alphavirus vaccines.
    McClain DJ; Pittman PR; Ramsburg HH; Nelson GO; Rossi CA; Mangiafico JA; Schmaljohn AL; Malinoski FJ
    J Infect Dis; 1998 Mar; 177(3):634-41. PubMed ID: 9498442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
    Erasmus JH; Seymour RL; Kaelber JT; Kim DY; Leal G; Sherman MB; Frolov I; Chiu W; Weaver SC; Nasar F
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29187545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.
    Rico AB; Phillips AT; Schountz T; Jarvis DL; Tjalkens RB; Powers AM; Olson KE
    Virology; 2016 Dec; 499():30-39. PubMed ID: 27632563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
    Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique epitopes recognized by antibodies induced in Chikungunya virus-infected non-human primates: implications for the study of immunopathology and vaccine development.
    Kam YW; Lee WW; Simarmata D; Le Grand R; Tolou H; Merits A; Roques P; Ng LF
    PLoS One; 2014; 9(4):e95647. PubMed ID: 24755730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope.
    Kim AS; Kafai NM; Winkler ES; Gilliland TC; Cottle EL; Earnest JT; Jethva PN; Kaplonek P; Shah AP; Fong RH; Davidson E; Malonis RJ; Quiroz JA; Williamson LE; Vang L; Mack M; Crowe JE; Doranz BJ; Lai JR; Alter G; Gross ML; Klimstra WB; Fremont DH; Diamond MS
    Cell; 2021 Aug; 184(17):4414-4429.e19. PubMed ID: 34416146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the Role of E2 Protein Domains in Alphavirus Pathogenicity.
    Weger-Lucarelli J; Aliota MT; Wlodarchak N; Kamlangdee A; Swanson R; Osorio JE
    J Virol; 2015 Dec; 90(5):2418-33. PubMed ID: 26676771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress.
    Fox JM; Long F; Edeling MA; Lin H; van Duijl-Richter MKS; Fong RH; Kahle KM; Smit JM; Jin J; Simmons G; Doranz BJ; Crowe JE; Fremont DH; Rossmann MG; Diamond MS
    Cell; 2015 Nov; 163(5):1095-1107. PubMed ID: 26553503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy.
    Fong RH; Banik SS; Mattia K; Barnes T; Tucker D; Liss N; Lu K; Selvarajah S; Srinivasan S; Mabila M; Miller A; Muench MO; Michault A; Rucker JB; Paes C; Simmons G; Kahle KM; Doranz BJ
    J Virol; 2014 Dec; 88(24):14364-79. PubMed ID: 25275138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deinococcus Mn
    Gayen M; Gupta P; Morazzani EM; Gaidamakova EK; Knollmann-Ritschel B; Daly MJ; Glass PJ; Maheshwari RK
    Vaccine; 2017 Jun; 35(29):3672-3681. PubMed ID: 28576570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge.
    Henning L; Endt K; Steigerwald R; Anderson M; Volkmann A
    Front Immunol; 2020; 11():598847. PubMed ID: 33542715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses.
    Reed DS; Glass PJ; Bakken RR; Barth JF; Lind CM; da Silva L; Hart MK; Rayner J; Alterson K; Custer M; Dudek J; Owens G; Kamrud KI; Parker MD; Smith J
    J Virol; 2014 Oct; 88(20):12077-86. PubMed ID: 25122801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress.
    Williamson LE; Reeder KM; Bailey K; Tran MH; Roy V; Fouch ME; Kose N; Trivette A; Nargi RS; Winkler ES; Kim AS; Gainza C; Rodriguez J; Armstrong E; Sutton RE; Reidy J; Carnahan RH; McDonald WH; Schoeder CT; Klimstra WB; Davidson E; Doranz BJ; Alter G; Meiler J; Schey KL; Julander JG; Diamond MS; Crowe JE
    Cell; 2021 Aug; 184(17):4430-4446.e22. PubMed ID: 34416147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A chimeric vesiculo/alphavirus is an effective alphavirus vaccine.
    Chattopadhyay A; Wang E; Seymour R; Weaver SC; Rose JK
    J Virol; 2013 Jan; 87(1):395-402. PubMed ID: 23077320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus.
    Muthumani K; Lankaraman KM; Laddy DJ; Sundaram SG; Chung CW; Sako E; Wu L; Khan A; Sardesai N; Kim JJ; Vijayachari P; Weiner DB
    Vaccine; 2008 Sep; 26(40):5128-34. PubMed ID: 18471943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
    Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two Conserved Phenylalanine Residues in the E1 Fusion Loop of Alphaviruses Are Essential for Viral Infectivity.
    Lucas CJ; Davenport BJ; Carpentier KS; Tinega AN; Morrison TE
    J Virol; 2022 May; 96(9):e0006422. PubMed ID: 35416719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.